191 related articles for article (PubMed ID: 17489570)
1. The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
Westaway SM
J Med Chem; 2007 May; 50(11):2589-96. PubMed ID: 17489570
[No Abstract] [Full Text] [Related]
2. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
3. Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature.
Voight EA; Kort ME
Expert Opin Ther Pat; 2010 Sep; 20(9):1107-22. PubMed ID: 20586701
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
Blum CA; Caldwell T; Zheng X; Bakthavatchalam R; Capitosti S; Brielmann H; De Lombaert S; Kershaw MT; Matson D; Krause JE; Cortright D; Crandall M; Martin WJ; Murphy BA; Boyce S; Jones AB; Mason G; Rycroft W; Perrett H; Conley R; Burnaby-Davies N; Chenard BL; Hodgetts KJ
J Med Chem; 2010 Apr; 53(8):3330-48. PubMed ID: 20307063
[TBL] [Abstract][Full Text] [Related]
5. Answering the burning question of how transient receptor potential vanilloid-1 channel antagonists cause unwanted hyperthermia.
Ayoub SS; Hunter JC; Simmons DL
Pharmacol Rev; 2009 Sep; 61(3):225-7. PubMed ID: 19805475
[TBL] [Abstract][Full Text] [Related]
6. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.
Szallasi A; Cortright DN; Blum CA; Eid SR
Nat Rev Drug Discov; 2007 May; 6(5):357-72. PubMed ID: 17464295
[TBL] [Abstract][Full Text] [Related]
7. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.
Gunthorpe MJ; Chizh BA
Drug Discov Today; 2009 Jan; 14(1-2):56-67. PubMed ID: 19063991
[TBL] [Abstract][Full Text] [Related]
8. Adlea (ALGRX-4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief.
Remadevi R; Szallisi A
IDrugs; 2008 Feb; 11(2):120-32. PubMed ID: 18240098
[TBL] [Abstract][Full Text] [Related]
9. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
[TBL] [Abstract][Full Text] [Related]
10. Modulation of intracellular calcium influences capsaicin-induced currents of TRPV-1 and voltage-activated channel currents in nociceptive neurones.
Hagenacker T; Büsselberg D
J Peripher Nerv Syst; 2007 Dec; 12(4):277-84. PubMed ID: 18042138
[TBL] [Abstract][Full Text] [Related]
11. Estrogen amplifies pain responses to uterine cervical distension in rats by altering transient receptor potential-1 function.
Yan T; Liu B; Du D; Eisenach JC; Tong C
Anesth Analg; 2007 May; 104(5):1246-50, tables of contents. PubMed ID: 17456681
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of vanilloid transient receptor potential cation channels.
Vriens J; Appendino G; Nilius B
Mol Pharmacol; 2009 Jun; 75(6):1262-79. PubMed ID: 19297520
[TBL] [Abstract][Full Text] [Related]
13. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
[TBL] [Abstract][Full Text] [Related]
14. QX-314 produces long-lasting local anesthesia modulated by transient receptor potential vanilloid receptors in mice.
Ries CR; Pillai R; Chung CC; Wang JT; MacLeod BA; Schwarz SK
Anesthesiology; 2009 Jul; 111(1):122-6. PubMed ID: 19512885
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of cochinchinenin B on capsaicin-activated responses in rat dorsal root ganglion neurons.
Wang ST; Chen S; Guo M; Liu XM
Brain Res; 2008 Mar; 1201():34-40. PubMed ID: 18294619
[TBL] [Abstract][Full Text] [Related]
16. Transient receptor potential channels on sensory nerves.
Eid SR; Cortright DN
Handb Exp Pharmacol; 2009; (194):261-81. PubMed ID: 19655110
[TBL] [Abstract][Full Text] [Related]
17. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
Knotkova H; Pappagallo M; Szallasi A
Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
[TBL] [Abstract][Full Text] [Related]
18. Hot receptors in the brain.
Steenland HW; Ko SW; Wu LJ; Zhuo M
Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of indole-based peptoids as potent noncompetitive antagonists of transient receptor potential vanilloid 1.
Quintanar-Audelo M; Fernández-Carvajal A; Van Den Nest W; Carreño C; Ferrer-Montiel A; Albericio F
J Med Chem; 2007 Nov; 50(24):6133-43. PubMed ID: 17985859
[TBL] [Abstract][Full Text] [Related]
20. Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief.
Jancsó G; Dux M; Oszlács O; Sántha P
Br J Pharmacol; 2008 Dec; 155(8):1139-41. PubMed ID: 18997813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
